Original paper
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
Volume: 39, Issue: 8, Pages: 689 - 698
Published: Jul 3, 2009
Abstract
Background Postprandial hyperlipidaemia is known to be a high‐risk factor for atherosclerotic disease because of rapid and lasting accumulations of triglyceride‐rich lipoproteins and remnants. The Niemann‐Pick C1‐Like 1 (NPC1L1) protein acts as an intestinal cholesterol transporter and ezetimibe, which inhibits NPC1L1, has been used in patients with hypercholesterolaemia. We investigated effects of ezetimibe on fasting lipid and lipoprotein...
Paper Details
Title
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
Published Date
Jul 3, 2009
Volume
39
Issue
8
Pages
689 - 698
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History